Cargando…
Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials
The time course of the response to each drug is important to avoid inappropriate termination of treatment by misjudging tumor progression; however, little is known about soft tissue sarcoma (STS) regarding this matter. This study aimed to perform a time‐lapse analysis of tumor response in patients w...
Autores principales: | Endo, Makoto, Takahashi, Shunji, Araki, Nobuhito, Sugiura, Hideshi, Ueda, Takafumi, Yonemoto, Tsukasa, Takahashi, Mitsuru, Morioka, Hideo, Hiraga, Hiroaki, Hiruma, Toru, Kunisada, Toshiyuki, Matsumine, Akihiko, Goda, Kazato, Kawai, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286446/ https://www.ncbi.nlm.nih.gov/pubmed/32220056 http://dx.doi.org/10.1002/cam4.2991 |
Ejemplares similares
-
Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies
por: Takahashi, Mitsuru, et al.
Publicado: (2017) -
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma
por: Morioka, Hideo, et al.
Publicado: (2016) -
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
por: Kawai, Akira, et al.
Publicado: (2017) -
The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study
por: Nakamura, Tomoki, et al.
Publicado: (2016) -
A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup
por: Kawai, Akira, et al.
Publicado: (2016)